by Richard A. Hendricks | Mar 17, 2021 | Health News
The clinical trial, called the KidCOVE study, will enroll approximately 6,750 children in the US and Canada between the ages of 6 months and 11 years old. The trial is broken into two parts. In part one, different dosages of the vaccine are being tested on the children. Children between the ages of 6 months […]
by Richard A. Hendricks | Jan 29, 2021 | Health News
Novavax said Thursday that its vaccine was found to have been 95.6% effective against the original novel coronavirus, and 85.6% effective against the variant first identified in the UK, known as B.1.1.7, based on results from a Phase 3 trial conducted in the UK. The...
by Richard A. Hendricks | Sep 25, 2020 | Health News
The trial has been on hold in the United States for more than two weeks, and regulators face the task of trying to figure out if these illnesses were random and disconnected from the vaccine, or if they are related to the vaccine. AstraZeneca and its partner, the...
by Richard A. Hendricks | Sep 17, 2020 | Health News
The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5. Four days later, AstraZeneca dismissed...
by Richard A. Hendricks | Sep 15, 2020 | Health News
“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a...
